Cancer Research and Treatment

Systematic review and meta-analysis of prediction models used in cervical cancer

Ashish Kumar Jha, Sneha Mithun, Umeshkumar B. Sherkhane, Vinay Jaiswar, Biche Osong, Nilendu Purandare, Sadhana Kannan, Kumar Prabhash, Sudeep Gupta, Ben Vanneste, Venkatesh Rangarajan, Andre Dekker, Leonard Wee

Artificial Intelligence in Medicine.2023; 139: 102549. CrossRef

Development and validation of radiomic signature for predicting overall survival in advanced stage cervical cancer

Ashish Kumar Jha, Sneha Mithun, Umeshkumar B. Sherkhane, Vinay Jaiswar, Sneha Shah, Nilendu Purandare, Kumar Prabhash, Amita Maheshwari, Sudeep Gupta, Leonard Wee, V. Rangarajan, Andre Dekker

Frontiers in Nuclear Medicine.2023;[Epub] CrossRef

Advanced cervical stump cancer after laparoscopic subtotal hysterectomy: a case report of imaging, laparoscopic staging and treatment approach

Dimitrios Andrikos, Argyrios Andrikos, Antoine Naem, Olga Ebertz, Rajesh Devassy, Rudy Leon De Wilde, Michael Khamou, Harald Krentel

Successful neoadjuvant chemotherapy plus sintilimab for locally advanced cervical cancer: case series and review of the literature

Linlin Liu, Xianbo Deng, Shuang Guo, Shouhua Yang

Diagnostic Pathology.2023;[Epub] CrossRef

Influence of the Clinical Nursing Pathway on Nursing Outcomes and Complications of Cervical Carcinoma Patients Undergoing Chemotherapy via PICC

Hongxia Tang, Li Gao, Yahui Li, Zhiqian Zhang

Evidence-Based Complementary and Alternative Medicine.2022; 2022: 1. CrossRef

Current and future direction in treatment of HPV-related cervical disease

Niloofar Khairkhah, Azam Bolhassani, Reza Najafipour

Journal of Molecular Medicine.2022; 100(6): 829. CrossRef

Machine Learning of Dose-Volume Histogram Parameters Predicting Overall Survival in Patients with Cervical Cancer Treated with Definitive Radiotherapy

Zhiyuan Xu, Li Yang, Qin Liu, Hao Yu, Longhua Chen, Claudia Marchetti

Journal of Oncology.2022; 2022: 1. CrossRef

Efficacy and safety of pembrolizumab on cervical cancer: A systematic review and single-arm meta-analysis

Lin Qi, Ning Li, Aimin Lin, Xiuli Wang, Jianglin Cong

Frontiers in Oncology.2022;[Epub] CrossRef

Outcomes and prognostic factors in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy

The comparative study for survival outcome of locally advanced cervical cancer treated by neoadjuvant arterial interventional chemotherapy or intravenous chemotherapy followed by surgery or concurrent chemoradiation

Yi Sun, Gailing Li, Panpan Hai, Yuan Cao, Pin Han, Yuchen Liu, Jing Wen, Yuanpei Wang, Xiaoran Cheng, Fang Ren

World Journal of Surgical Oncology.2022;[Epub] CrossRef

Pembrolizumab for advanced cervical cancer: safety and efficacy

Francesca De Felice, Elena Giudice, Giulia Bolomini, Maria Grazia Distefano, Giovanni Scambia, Anna Fagotti, Claudia Marchetti

Expert Review of Anticancer Therapy.2021; 21(2): 221. CrossRef

Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer

Yifan Feng, Ye Wang, Yangqin Xie, Shuwei Wu, Yuyang Li, Min Li

Comparison of therapeutic effects of chemo-radiotherapy with neoadjuvant chemotherapy before radical surgery in patients with bulky cervical carcinoma (stage IB3 & IIA2)

Setareh Akhavan, Abbas Alibakhshi, Mahdieh Parsapoor, Abbas Alipour, Elahe Rezayof

Macleayins A From Macleaya Promotes Cell Apoptosis Through Wnt/β-Catenin Signaling Pathway and Inhibits Proliferation, Migration, and Invasion in Cervical Cancer HeLa Cells

Chunmei Sai, Wei Qin, Junyu Meng, Li-Na Gao, Lufen Huang, Zhen Zhang, Huannan Wang, Haixia Chen, Chaohua Yan

Frontiers in Pharmacology.2021;[Epub] CrossRef

Nomogram Predicting Overall Survival in Patients with FIGO II to III Squamous Cell Cervical Carcinoma Under Radical Radiotherapy: A Retrospective Analysis Based on 2018 FIGO Staging

Lele Zang, Qin Chen, Xiaozhen Zhang, Xiaohong Zhong, Jian Chen, Yi Fang, An Lin, Min Wang

Cancer Management and Research.2021; Volume 13: 9391. CrossRef

Prediction of early response to concurrent chemoradiotherapy in cervical cancer: Value of multi-parameter MRI combined with clinical prognostic factors

Xiaomin Zheng, Weiqian Guo, Jiangning Dong, Liting Qian

Magnetic Resonance Imaging.2020; 72: 159. CrossRef

Calculating the overall survival probability in patients with cervical cancer: a nomogram and decision curve analysis-based study

Guilan Xie, Ruiqi Wang, Li Shang, Cuifang Qi, Liren Yang, Liyan Huang, Wenfang Yang, Mei Chun Chung

SPP1 inhibition improves the cisplatin chemo-sensitivity of cervical cancer cell lines

Xing Chen, Dongsheng Xiong, Liya Ye, Huichun Yang, Shuangshuang Mei, Jinhong Wu, Shanshan Chen, Ruoran Mi

Cancer Chemotherapy and Pharmacology.2019; 83(4): 603. CrossRef

Systemic therapy in cervical cancer: 30 years in review

Michalis Liontos, Anastasios Kyriazoglou, Ioannis Dimitriadis, Meletios-Athanasios Dimopoulos, Aristotelis Bamias

Critical Reviews in Oncology/Hematology.2019; 137: 9. CrossRef

Adjuvant chemoradiotherapy versus radiotherapy in cervical cancer patients with intermediate-risk factors: A systematic review and meta-analysis

Meng Li, Mengyang Hu, Yuanjian Wang, Xingsheng Yang

European Journal of Obstetrics & Gynecology and Reproductive Biology.2019; 238: 1. CrossRef

Neoadjuvant chemotherapy followed by radical hysterectomy for stage IB2-to-IIB cervical cancer: a retrospective cohort study

Lei Li, Ming Wu, Shuiqing Ma, Xianjie Tan, Sen Zhong

International Journal of Clinical Oncology.2019; 24(11): 1440. CrossRef

F. De Felice, C. Marchetti, I. Palaia, R. Ostuni, L. Muzii, V. Tombolini, P. Benedetti Panici

Critical Reviews in Oncology/Hematology.2018; 129: 40. CrossRef